Search Results 3481-3490 of 16469 for Chiari malformation
The Translational Nanomedicine Program at Mayo Clinic fosters integrated development of nanoparticle theory and technology to diagnose and treat cancer.
Using simulation science, our research team seeks to develop individualized therapies to optimize treatments for people with neurological diseases. Overview. In ...
In the wake of thoracic outlet syndrome, an outdoors enthusiast triumphs · About the News Network · Newsbureau@mayo.edu · News Releases · Cancer ...
Mayo Clinic researcher Garvan C. Kane, M.D., Ph.D., studies echocardiography to improve the diagnosis and outcomes of people with cardiovascular diseases.
... Syndrome-Diarrhea (IBS-D) Bile Acids, Genetic Control and Ileo-Colonic Mucosal Expression in IBS-D NCT ID: POC ID: CLS-20306541; Title: American Registry for ...
Title: VEXAS Syndrome Biorepository (VEXAS) VEXAS Biobank NCT ID: POC ID: CLS-20530269. Pagination Clinical Studies. PrevPrevious Page · Go to page 315315 · Go ...
... Syndrome with Excess Blasts Progressing On or After Azacitidine or Decitabine Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts ...
... Syndrome (LKS) A Study to Demonstrate that Acetazolamide is not Inferior to Diazepam for Patients who have Continuous Spike and Wave Brain Pattern in Sleep
... Syndrome LIVE-LQTS (LIVE-HCM/LQT) Exercise in Genetic Cardiovascular Conditions NCT ID: NCT02549664 POC ID: CLS-20306499. Pagination Clinical Studies. Prev ...
... Syndrome Due to Idiopathic Membranous Nephropathy (iMN) Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients NCT ID: NCT01386554 POC ID ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.